Similar articles

• A comparison of some of the pharmacological properties of etintidine, a new histamine H2-receptor antagonist, with those of cimetidine, ranitidine and tiotidine.

  Cavanagh RL, Usakewicz JJ, Buyniski JP. Cavanagh RL, et al. J Pharmacol Exp Ther. 1983 Jan;224(1):171-9. J Pharmacol Exp Ther. 1983. PMID: 6129316
• Effect of mifentidine on histamine-stimulated human atrium "in vitro": comparison with ranitidine and cimetidine.

  Poli E, Medici D, Contini GA, Bertaccini G. Poli E, et al. Arch Int Pharmacodyn Ther. 1985 Feb;273(2):221-5. Arch Int Pharmacodyn Ther. 1985. PMID: 2860879
• Studies on MK-208 (YM-11170) a new, slowly dissociable H2-receptor antagonist.

  Pendleton RG, Torchiana ML, Chung C, Cook P, Wiese S, Clineschmidt BV. Pendleton RG, et al. Arch Int Pharmacodyn Ther. 1983 Nov;266(1):4-16. Arch Int Pharmacodyn Ther. 1983. PMID: 6141772
• Comparison of famotidine with cimetidine and ranitidine.

  Berardi RR, Tankanow RM, Nostrant TT. Berardi RR, et al. Clin Pharm. 1988 Apr;7(4):271-84. Clin Pharm. 1988. PMID: 2896559 Review.
• A review of the animal pharmacology of ranitidine--a new, selective histamine H2-antagonist.

  Brittain RT, Daly MJ. Brittain RT, et al. Scand J Gastroenterol Suppl. 1981 Jun;69:1-9. Scand J Gastroenterol Suppl. 1981. PMID: 6119770 Review.